A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 trap) in patients with familial cold autoinflammatory syndrome-Reference-Cited by-同舟云学术

A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 trap) in patients with familial cold autoinflammatory syndrome

Published:2008-08 Issue:8 Volume:58 Page:2432-2442
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Goldbach-Mansky Raphaela,Shroff Sharukh D.,Wilson Mildred,Snyder Christopher,Plehn Sara,Barham Beverly,Pham Tuyet-Hang,Pucino Frank,Wesley Robert A.,Papadopoulos Joanne H.,Weinstein Steven P.,Mellis Scott J.,Kastner Daniel L.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference29 articles.

1. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome;Hoffman;Nat Genet,2001

2. Familial cold urticaria: a generalized reaction involving leukocytosis;Tindall;Arch Intern Med,1969

3. A case of cold urticaria with an unusual family history;Kile;JAMA,1940

4. Familial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant periodic fever;Hoffman;J Allergy Clin Immunol,2001

5. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes;Feldmann;Am J Hum Genet,2002

Cited by 199 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Utility of Rilonacept for the Treatment of Recurrent Pericarditis: Design, Development, and Place in Therapy;Drug Design, Development and Therapy;2024-09

2. AA Amyloidosis: A Contemporary View;Current Rheumatology Reports;2024-04-03

3. Practical Approach to Diagnosis and Management of IL-1-Mediated Autoinflammatory Diseases (CAPS, TRAPS, MKD, and DIRA);Pediatric Drugs;2024-02-20

4. Protein-protein interactions and related inhibitors involved in the NLRP3 inflammasome pathway;Cytokine & Growth Factor Reviews;2023-12

5. The role of macrophages in rosacea: implications for targeted therapies;Frontiers in Immunology;2023-08-24